Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Veracyte, Inc. logo

Veracyte, Inc.

About

45.03USD-0.16 -0.35%
Closed • Updated at 22:10 GMT+00:00
Market Cap$3.59B
P/E Ratio41.45
Volume1.40M
Beta1.61
RSI73.75
Gross Margin69.97%
Health TechnologyMedical Specialties

Veracyte, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
May 15 2026
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer
May 5 2026
Veracyte Announces First Quarter 2026 Financial Results
Apr 28 2026
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
Apr 14 2026
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026

Community Chat

Ask AI

Try asking
6ix6ixAIEvents